The Dampness Syndrome of Chinese Medicine Cohort Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age35-79
SponsorGuangzhou University of Traditional Chinese Medicine

About this trial

The researchers plain to build a large-scale, longitudinal, prospective cohort characterized by TCM dampness syndrome. With the biobank of this cohort the investigators want to find the causality between TCM dampness syndrome and clinical chronic diseases and a new way to treat clinical disease.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Residents aged 30 to 79, whose residence is consistent with their registered permanent residence location;

Residents who voluntarily participate in the project, agree to the collection of their biological information, and sign the informed consent form;

Residents who have no mental illness and other related diseases, and display a normal ability of expression and understanding;

Disqualifiers

Residents who reject collaboration;

Residents who allow no follow-up visits.

Trial population

general population in a specific area and specifc time range. Such as civil servants of Guangdong Province. Medical workers in Xinjiang.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • natural aging process

    Other intervention

    To observe the relationship between new cases of diseases and health status of people exposed to different factors such as life style, alcohol consumption, eating habits, etc.

Treatment groups

100,000 Participants
are divided into 1 treatment group
Group A: general population1 intervention

Trial outcomes

Primary outcomes

1

emerging diseases

This study will pay attention to the emerging situation of clinical chronic diseases, such as cancer, diabetes, hypertension, coronary heart disease, dementia, etc. Each follow-up the researchers will record the incidence of the emerging diseases of interviewees' by questionnaire including the name of the disease, time of onset and treatments.

Time frame
through study completion, an average of 1 year

Secondary outcomes

1

Montreal Cognitive Assessment(MoCA)

MoCA is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA is the most sensitive test available for detecting Alzheimer's disease, measuring executive functions and multiple cognitive domains. The value range 0-30: higher scores mean a better Cognitine. The score above 26 is considered the normal congnitive level

Time frame
through study completion, an average of 1 year
2

European Quality of Life 5-dimensional questionnaire (EQ-5D-5L)

The EQ-5D comprises five dimensions of health: mobility, ability to self-care, ability to undertake usual activities, pain and discomfort, and anxiety and depression. . EQ-5D-5L, includes five levels of severity for each dimension (no problems, slight problems, moderate problems, severe problems, and extreme problems). The value range 0-100: higher scores mean a worse outcome.

Time frame
through study completion, an average of 1 year
3

Mini-Mental State Exam (MMSE)

MMSE is a widely used test of cognitive function among the elderly; it includes tests of orientation, attention, memory, language and visual-spatial skills. The value range 0-30: higher scores mean a better Cognitine.

Time frame
through study completion, an average of 1 year
4

interview questionnaire

Demographic characteristic, life style. disease history, allergies will be involoved.

Time frame
through study completion, an average of 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Guangzhou University of Traditional Chinese Medicine

Lead sponsor

State Key Laboratory of Dampness Syndrome of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine

Collaborator